Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 EUR | -0.44% | -0.44% | -14.12% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.12% | 83.74M | - | ||
+14.91% | 83.02B | C+ | ||
+11.06% | 29.97B | C+ | ||
-12.02% | 16.99B | B | ||
-5.56% | 15.93B | A- | ||
-7.91% | 14.15B | A- | ||
-0.10% | 12.08B | A- | ||
-30.35% | 11.8B | - | - | |
+21.84% | 11.38B | B- | ||
-6.38% | 10.91B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- V3V Stock
- Ratings VITA 34 AG